English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The robotic platforms have become reality in the endoscopic field. Different technologies are suitable with different characteristics. The robotic surgical applications are various in different specialties. The gynecologic applications are different both for benign and malignant conditions. However, one of the main limits is represented by high costs and increased operative time. In this context, the Senhance (TransEnterix Surgical Inc., Morrisville, NC, USA) robotic platform took place thanks to different characteristics as 3D eye tracking camera control system and haptic feedback that allowed to control the tissue traction reducing the risk of surgical damage. The Senhance platform was deeply investigated in the last years and tested in different pathologies as benign and malignant conditions reporting good results even compared with standard laparoscopy. The present surgical technique article is aimed to show the conservative staging for borderline ovarian tumor approached with the Senhance platform. The surgery consists of robotic-assisted right ovarian cyst enucleation and omental and peritoneal biopsies in a 29 years old patient. The surgical setting adopted was the same as standard laparoscopy, with 12 mm umbilical trocar, and 5 mm trocar in left and right iliac fossa, and one in suprapubic area. The operative time was 40 and 9 minutes for robotic arms installation. The estimated blood loss was 25 mL. The hospital stay was 1 day without early and late complications recorded.

Senhance robotic platform for ovarian borderline tumor treatment: minimally invasive robotic approach for conservative adnexal surgery